Please log in with your CIONET Account for the best experience on this page. You can continue to access this page without logging in by simply closing this window, but logging in will make your life easier. The advantages of being logged in on the website of CIONET are that:
You get personalised content;
You have access to additional services and content based on your Account Level; and
It will require less user input to sign up for our events.
(If you don't want to create an account, you can click the cross and proceed to the registration page)
AI proficiency is becoming strategically important. This is especially true in the pharmaceutical sector.. l Its industry leaders recognise that advanced AI applications, focussing on improving efficiency and outcomes, are key to gaining a competitive advantage. It's widely accepted that AI offers unprecedented opportunities to enhance R&D, streamline operations, and improve patient outcomes. As the sector evolves from specific AI use cases to a future dominated by the multifaceted impact of AI-driven technologies on all stages of the pharmaceutical life cycle, there is an increasing need for robust AI adoption strategies..
This CIONET roundtable explores how to build robust AI adoption strategies that prepare pharmaceutical companies for a future dominated by AI-driven technologies.
We will discuss the following five critical pillars for successful AI adoption:
AI- first business and operation models that embed AI-driven decision-making across functions
Technology stack enhancements to support large-scale AI deployment and innovation
Comprehensive AI-ready data strategies ensuring security, compliance and accuracy
Workforce readiness for AI, addressing chnge management and interdisciplinary skill development
Risk and compliance frameworks ensuring AI governance, transparency and cybersecurity
Speakers
Prof. Stein Aerts
Scientific Director VIB.AI
VIB
Programme
Join us to discuss how to scale AI initiatives, foster cross-functional collaboration, and unlock the true potential of AI to drive innovation and efficiency across your pharmaceutical enterprise.
.png)